Cogent Biosciences Inc (NASDAQ: COGT) kicked off on Tuesday, down -3.88% from the previous trading day, before settling in for the closing price of $8.76. Over the past 52 weeks, COGT has traded in a range of $5.37-$12.61.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -41.25%. While this was happening, its average annual earnings per share was recorded -0.39%. With a float of $88.88 million, this company’s outstanding shares have now reached $110.46 million.
Let’s determine the extent of company efficiency that accounts for 164 employees. In terms of profitability, gross margin is 47.39%, operating margin of -4660.58%, and the pretax margin is -4336.02%.
Cogent Biosciences Inc (COGT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Cogent Biosciences Inc is 19.54%, while institutional ownership is 92.49%. The most recent insider transaction that took place on Jan 14 ’25, was worth 332,412. In this transaction Chief Commercial Officer of this company bought 43,750 shares at a rate of $7.60, taking the stock ownership to the 45,848 shares.
Cogent Biosciences Inc (COGT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.64 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.39% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.60% during the next five years compared to 15.33% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Take a look at Cogent Biosciences Inc’s (COGT) current performance indicators. Last quarter, stock had a quick ratio of 6.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.48, a number that is poised to hit -0.59 in the next quarter and is forecasted to reach -2.33 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Looking closely at Cogent Biosciences Inc (NASDAQ: COGT), its last 5-days average volume was 1.58 million, which is a jump from its year-to-date volume of 1.57 million. As of the previous 9 days, the stock’s Stochastic %D was 16.83%. Additionally, its Average True Range was 0.60.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 30.28%, which indicates a significant increase from 23.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 70.70% in the past 14 days, which was higher than the 58.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.51, while its 200-day Moving Average is $9.24. However, in the short run, Cogent Biosciences Inc’s stock first resistance to watch stands at $8.76. Second resistance stands at $9.11. The third major resistance level sits at $9.46. If the price goes on to break the first support level at $8.07, it is likely to go to the next support level at $7.72. Now, if the price goes above the second support level, the third support stands at $7.37.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
The company with the Market Capitalisation of 930.09 million has total of 110,462K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -192,410 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -70,630 K.
